Eli Lilly’s obesity and diabetes treatments fuel growth and spark bidding war
Mounjaro and Zepbound have brought in nearly $25 billion in sales so far this year for Lilly.
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
What did you think of this news? Leave a comment below and/or share it on your social media. This way, we can inform more people about the hottest things in technology, science, innovation, and gaming!
This news was originally published in:
Original source
